Xcout IntelValneva SE
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.
Subscribe to see Valneva SE’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Valneva SE at a glance
Valneva SE is a biotechnology company headquartered in Saint-Herblain, France. It is publicly listed (VALN) with a market capitalisation of $539.5M. Xcout tracks 18 named people at Valneva SE, including Thomas Lingelbach (President, Chief Executive Officer & Director). Xcout recorded 3 job postings from Valneva SE in the last 90 days.
Valneva SE leadership
- Thomas LingelbachPresident, Chief Executive Officer & Director
- Vincent DequenneChief Operating Officer
- Peter BuhlerChief Financial Officer
- Peter BühlerChief Financial Officer
- Juan-Carlos JaramilloChief Medical Officer
- Dipal PatelChief Commercial Officer
12 more named people on record for Valneva SE, with roles, board committees and tenure — see the full roster →
Hiring at Valneva SE
Xcout recorded 3 job postings from Valneva SE in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Valneva SE's hiring signals →
Valneva SE competitors
A few of Valneva SE's closest competitors — see the full list of competitors and alternatives →
Marinomed Biotech AG is an Austrian, science-driven biotech company headquartered in Korneuburg, Austria. The company is listed on the stock exchange.
Abivax S.A., operating as ABIVAX Société Anonyme, is a French pharmaceutical firm focused on the discovery and optimization of therapeutic drugs for inflammatory, infectious, and oncological diseases. A cornerstone of their product pipeline is ABX464, which is currently undergoing Phase IIb clinical trials for ulcerative colitis, Crohn's Disease, and COVID-19. This compound is also being evaluated in Phase IIa studies for rheumatoid arthritis and has successfully completed Phase IIa trials demonstrating viral remission in patients with HIV. Additionally, the company is advancing ABX 196, an immune-boosting candidate, through Phase 1/2 clinical trials targeting hepatocellular cancer. Abivax also conducts research initiatives for conditions like Dengue fever, influenza, and respiratory syncytial virus. The company has secured license agreements with key French scientific bodies, including the National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. Founded in 2013, Abivax S.A. maintains its headquarters in Paris, France.
MalarVx, Inc. is a clinical-stage biopharmaceutical vaccine company located in Seattle, Washington, founded to develop innovative vaccines addressing global infectious diseases.
Bavarian Nordic A/S is a fully integrated biotechnology company focused on the research, development, and manufacturing of life-saving vaccines. The company serves healthcare professionals, patients, and global markets by delivering innovative vaccine products and solutions.
Icosavax, Inc. is a Seattle, Washington-based clinical-stage biopharmaceutical company specializing in developing novel vaccines utilizing virus-like particle technology.
Hookipa Pharma Inc. is a clinical-stage biotechnology company developing immunotherapies and vaccines based on arenavirus vectors, designed to stimulate targeted T-cell and antibody responses. Its programs have focused on cancer and infectious diseases, serving patients through potential therapeutic and preventive treatments.
Get Valneva SE's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Valneva SE in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 3 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access